Genenta Science S.p.A. (GNTA) Executive Compensation
Genenta Science S.p.A. (GNTA) is a publicly traded company on the Nasdaq, categorized under SIC 2836 (Biological Products, (No Diagnostic Substances)). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: GNTA
CIK: 1838716
Exchange: Nasdaq
SIC 2836: Biological Products, (No Diagnostic Substances)
State: L6
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
Dannible & McKee, LLP
Auditor SinceSince 12/31/2022 12:00:00 AM
Lead Engagement PartnerJoseph Chemotti
Audit LocationSyracuse, New York, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 6-K | 2026-10-13 | 2026-10-13 | 6-K | 0001493152-26-046816 | View SEC Doc Filr Page |
| 6-K | 2026-10-07 | 2026-10-07 | 6-K | 0001493152-26-046136 | View SEC Doc Filr Page |
| SCHEDULE 13D/A | 2026-10-02 | — | SCHEDULE 13D/A Filing | 0001493152-26-045500 | View SEC Doc Filr Page |
| 6-K | 2026-09-11 | 2026-09-11 | 6-K | 0001493152-26-042377 | View SEC Doc Filr Page |
| 6-K | 2026-09-02 | 2026-09-01 | 6-K | 0001493152-26-041066 | View SEC Doc Filr Page |
| 6-K | 2026-07-31 | 2026-07-31 | 6-K | 0001493152-26-035626 | View SEC Doc Filr Page |
| 6-K | 2026-07-14 | 2026-07-14 | 6-K | 0001493152-26-033176 | View SEC Doc Filr Page |
| 6-K | 2026-07-01 | 2026-07-01 | 6-K | 0001493152-26-031546 | View SEC Doc Filr Page |
| 6-K | 2026-06-26 | 2026-06-26 | 6-K | 0001493152-26-030282 | View SEC Doc Filr Page |
| 6-K | 2026-06-24 | 2026-06-24 | 6-K | 0001493152-26-029882 | View SEC Doc Filr Page |
| 6-K | 2026-06-17 | 2026-06-17 | 6-K | 0001493152-26-029000 | View SEC Doc Filr Page |
| 6-K | 2026-06-16 | 2026-06-16 | 6-K | 0001493152-26-028831 | View SEC Doc Filr Page |
| 6-K | 2026-05-29 | 2026-05-29 | 6-K | 0001493152-26-026354 | View SEC Doc Filr Page |
| 6-K | 2026-05-19 | 2026-05-19 | 6-K | 0001493152-26-024451 | View SEC Doc Filr Page |
| SCHEDULE 13D | 2026-05-05 | — | SCHEDULE 13D Filing | 0001493152-26-021319 | View SEC Doc Filr Page |
| 4 | 2026-05-05 | 2026-03-30 | 4 | 0001493152-26-021237 | View SEC Doc Filr Page |
| 6-K | 2026-04-28 | 2026-04-28 | 6-K | 0001493152-26-019327 | View SEC Doc Filr Page |
| 6-K | 2026-04-23 | 2026-04-23 | 6-K | 0001493152-26-018713 | View SEC Doc Filr Page |
| 6-K | 2026-04-14 | 2026-04-14 | 6-K | 0001493152-26-016540 | View SEC Doc Filr Page |
| 4 | 2026-04-01 | 2026-03-30 | 4 | 0001493152-26-014634 | View SEC Doc Filr Page |
| 4 | 2026-04-01 | 2026-03-30 | 4 | 0001493152-26-014633 | View SEC Doc Filr Page |
| 4 | 2026-04-01 | 2026-03-30 | 4 | 0001493152-26-014631 | View SEC Doc Filr Page |
| 4 | 2026-04-01 | 2026-03-30 | 4 | 0001493152-26-014630 | View SEC Doc Filr Page |
| 4 | 2026-04-01 | 2026-03-30 | 4 | 0001493152-26-014629 | View SEC Doc Filr Page |
| 20-F | 2026-04-01 | 2025-12-31 | 20-F | 0001493152-26-014387 | View SEC Doc Filr Page |